Also, it was reported that anti-NS1 can sero-cross with platelets and cause temporary thrombocytopenia and hemorrhage, which demonstrates that these anti-platelets antibodies are pathogenic.
Igual, se ha reportado que los anti-NS1 pueden serocruzar con plaquetas y causar una trombocitopenia temporal y hemorragia, lo que demuestra que estos anticuerpos antiplaquetarios son patogénicos.